Medical Developments International Limited (MVP) - Research

$5.300
Prices as at 15:36, 25 Apr 2019

MVP Current Share Price+

Current Price $5.300
Open $5.300
High $5.350
Low $5.290
Last Close $5.300
Volume 48517
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

MVP General Information

Medical Developments International Limited
MVP
http://www.medicaldev.com
Pharmaceuticals
346
66

MVP Company Overview

Business Description

Medical Developments International Limited (MVP) is an Australia-based healthcare company. MVP offers a range of open and closed circuit anaesthetic machines to the veterinary market, which are known as Komesaroff anaesthetic machines. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment. Company has established a network of manufactures and distributors to ensure both quality assurance and supply chain solutions are maintained for servicing and delivering to both the local and international sectors.

MVP Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 F 0.00 2.80 188.70% 189.30 4.00 0.80% 0.0%
2019 F 0.00 1.00 136.60% 546.40 4.00 0.80% 0.0%
2018 A 0.24 0.40 -86.80% 1,542.00 4.00 0.60% 100.0%

MVP Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2018 A 2019 F 2020 F 2018 A 2019 F 2020 F 2018 A 2019 F 2020 F
Medical Developments International (MVP) $345M -0.8677 1.3659 1.8866 1,285.3659 543.2990 188.2143 0.76% 0.76% 0.76%
Mayne Pharma Group (MYX) $1,084M -0.5645 0.2021 0.6145 23.8676 19.8551 12.2980 0.00% 0.00% 0.00%
Starpharma (SPL) $476M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

MVP Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 3.00 611.20 14.90 3.79
Market 0.71 14.90 1.20 1.08
Sector 1.02 24.40 3.31 2.83

MVP Directors

Name Position Start Date
Mr David Williams Non-Executive Chairman, Non-Executive Director 16 Sep 2003
Mr Philip (Phil) John Powell Non-Executive Director 17 Dec 2014
Mr Robert (Max) Maxwell Johnston Non-Executive Director 5 Nov 2012
Mr Leon Hoare Non-Executive Director 27 Sep 2013

MVP Management

Name Position
John Stewart Sharman Chief Executive Officer
Mark Edwards Group Financial Controller,Company Secretary

MVP Substantial Shareholders

Holding Name
9,459,584 (14.93%) Williams, David John

MVP Calendar of Events

Date Event
19 February 2020 Report (Interim)
20 September 2019 Report (Annual)
16 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.